In this role, Mr Cuneo is responsible for coordinating Mylan’s global business development and strategic efforts in close alignment with the company’s executive leadership team.
Mr Cuneo joins Mylan from Merrill Lynch, a financial management and advisory firm, where he worked for more than a decade on strategic advisory and capital markets transactions, primarily in the healthcare sector. Most recently Mr Cuneo served as a director in its global healthcare investment banking group.
Robert Coury, vice chairman and CEO of Mylan, said: “Drew brings a wealth of experience in the pharmaceutical, biotechnology and health care sectors. His familiarity with our and in particular with Mylan given his and Merrill Lynch’s active role with the company during the past five years – makes him ideally suited to support the company’s continued growth.”